Product How it works Pricing Blog FAQ About Contact
Assembly Biosciences

Assembly Biosciences (NASDAQ: ASMB) revenue

Assembly Biosciences reported revenue of $72.3m for fiscal 2025, 153.5% more than in fiscal 2024 ($28.5m).

Assembly Biosciences has grown its revenue for 2 years in a row, and its best year of the last 10 was fiscal 2020. The biggest drop was in fiscal 2021, −92.1%.

Revenue, in millions of US dollars0.020169.0201714.8201816.0201979.120206.320210.020227.2202328.5202472.32025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$72.3m+153.5%−$12.1m−16.8%
2024$28.5m+298.2%−$45.4m−159.3%
2023$7.2m—−$64.6m−902.5%
2022$0.0m−100.0%−$94.1m—
2021$6.3m−92.1%−$132.7m−2,121.7%
2020$79.1m+395.6%−$64.8m−81.9%
2019$16.0m+7.8%−$102.7m−643.4%
2018$14.8m+64.1%−$92.7m−626.4%
2017$9.0m—−$52.2m−579.1%
2016$0.0m—−$45.3m—

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Assembly Biosciences revenue compared with its sector

By revenue for its latest fiscal year, Assembly Biosciences ranks 310th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Assembly Biosciences, 153.5%.

RankCompanyRevenueRevenue growth
308thRecursion Pharmaceuticals$74.7m26.9%
309thElectromed$73.8m15.3%
310thAssembly Biosciences$72.3m153.5%
311thViridian Therapeutics$70.8m23,359.9%
312thCodexis$70.4m18.6%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Assembly Biosciences

How much revenue did Assembly Biosciences make in fiscal 2025?
Assembly Biosciences reported revenue of $72.3m for fiscal 2025, compared with $28.5m in fiscal 2024.
What was the best year for revenue at Assembly Biosciences?
Of its last 10 fiscal years, fiscal 2020, with $79.1m.
Where does Assembly Biosciences rank in its sector by revenue?
It ranks 310th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Assembly Biosciences come from?
From the annual report (Form 10-K) that Assembly Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Assembly Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Assembly Biosciences: the Assembly Biosciences page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.